BPTS - long - catalyst - low floater playBiophytis SA is a France-based biotechnology company focused on the development of therapeutics that slow the degenerative processes associated with aging and improve functional outcomes for patients suffering from age-related diseases. Its drug candidate, Sarconeos (BIO101), is an orally administer
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−17.03 M EUR
0.00 EUR
18.39 M
About BIOPHYTIS
Sector
Industry
CEO
Stanislas Veillet
Website
Headquarters
Paris
Founded
2006
ISIN
FR001400OLP5
FIGI
BBG00JRQT394
Biophytis SA operates as a clinical-stage biotechnology company. It specializes in the development of therapeutics that are aimed at slowing the degenerative processes associated with aging, including severe respiratory failure in patients suffering from COVID-19. Its products include Sarconeos (BIO101), which is used to treat sarcopenic obesity and Macuneos (BIO201), which is used to treat dry age-related macular degeneration (AMD). The company was founded by Stanislas Veillet and René Lafont on September 27, 2006 and is headquartered in Paris, France.
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Related stocks
Frequently Asked Questions
The current price of 0D1W is 0.1740 EUR — it has increased by 1.69% in the past 24 hours. Watch BIOPHYTIS EUR0.1 stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on LSE exchange BIOPHYTIS EUR0.1 stocks are traded under the ticker 0D1W.
0D1W stock has risen by 2.86% compared to the previous week, the month change is a −43.31% fall, over the last year BIOPHYTIS EUR0.1 has showed a −81.09% decrease.
We've gathered analysts' opinions on BIOPHYTIS EUR0.1 future price: according to them, 0D1W price has a max estimate of 0.77 EUR and a min estimate of 0.77 EUR. Watch 0D1W chart and read a more detailed BIOPHYTIS EUR0.1 stock forecast: see what analysts think of BIOPHYTIS EUR0.1 and suggest that you do with its stocks.
0D1W reached its all-time high on Jan 19, 2018 with the price of 1,744.0000 EUR, and its all-time low was 0.1701 EUR and was reached on Apr 7, 2025. View more price dynamics on 0D1W chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
0D1W stock is 3.45% volatile and has beta coefficient of 1.02. Track BIOPHYTIS EUR0.1 stock price on the chart and check out the list of the most volatile stocks — is BIOPHYTIS EUR0.1 there?
Yes, you can track BIOPHYTIS EUR0.1 financials in yearly and quarterly reports right on TradingView.
BIOPHYTIS EUR0.1 is going to release the next earnings report on Nov 4, 2025. Keep track of upcoming events with our Earnings Calendar.
No, 0D1W doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 0D1W shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BIOPHYTIS EUR0.1 stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So BIOPHYTIS EUR0.1 technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating BIOPHYTIS EUR0.1 stock shows the sell signal. See more of BIOPHYTIS EUR0.1 technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.